Randomized Parallel-Group Phase II Study (NEOTERIC) of Atezolizumab With or Without Tiragolumab After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.

Journal:
Journal of Clinical Oncology
Published:
DOI:
10.1200/jco-25-01883
Affiliations:
8
Authors:
13
Go to article
Institutions Authors Share
Zhongshan Hospital, Fudan University, China
3.000000
 0.23
Roche R&D Center (China) Ltd., China
2.000000
 0.15
State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, China
2.000000
 0.15
The Second Affiliated Hospital, Zhejiang University School of Medicine, China
2.000000
 0.15
The Sixth Affiliated Hospital, SYSU, China
2.000000
 0.15
The First Hospital of China Medical University, China
2.000000
 0.15
Interested in Oncology and Carcinogenesis?